Indian Immunologicals Limited has asserted that the rabies vaccine vials in question were not produced by their facility. Following a potency test failure, a batch was labeled substandard by the drug regulator. IIL emphasized that the Central Drugs Laboratory in Kasauli had assessed and approved the batch. The company identified seventeen discrepancies between the seized vials and their retention samples.

INDIA-RABIESVACCINE/COUNTERFEIT (EXCLUSIVE, PIX):EXCLUSIVE-India flags Abhayrab rabies vaccine batch as substandard, probes if spurious, document shows | India News

INDIA-RABIESVACCINE-COUNTERFEIT:Exclusive-India flags Abhayrab rabies vaccine batch as substandard, probes if spurious, document shows | India News

India’s drug regulator flags Abhayrab rabies vaccine batch after a potency test failure and discrepancies raise concerns over its identity and authenticity.

IIL defends its rabies vaccine amid CDSCO's seizure of misbranded vials from an unlicensed Delhi residence.